Group B Streptococcus (GBS) Infection Treatment Market was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 10.2% from 2024 to 2030.
The global market for Group B Streptococcus (GBS) infection treatment was valued at approximately $3.2 billion in 2022. It is projected to experience a Compound Annual Growth Rate (CAGR) of around 5.7% from 2023 to 2030. This growth is primarily driven by increasing awareness of GBS infections, advancements in diagnostic technologies, and the rising incidence of GBS among pregnant women and newborns. The demand for effective prophylactic and therapeutic treatments is fueling market expansion, as healthcare systems globally enhance their focus on preventing GBS-related complications.
Opportunities in the GBS infection treatment market are particularly notable in emerging regions, where rising healthcare infrastructure and growing awareness are creating new avenues for growth. Markets in Asia-Pacific, Latin America, and the Middle East are expected to see significant expansion due to increased healthcare investments and rising population awareness. The development of novel therapeutic agents and improved prophylactic measures are anticipated to drive market dynamics further. These factors present substantial opportunities for stakeholders looking to enter or expand within this growing market.
Get an In-Depth Research Analysis of the Global Group B Streptococcus (GBS) Infection Treatment Market Size And Forecast [2025-2032]
Pfizer Inc.
Alopexx Enterprises
LLC
Wellstat Vaccines LLC
Minervax ApS
Novartis
GlaxoSmithKline
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Group B Streptococcus (GBS) Infection Treatment Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Group B Streptococcus (GBS) Infection Treatment Market
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on Types the Market is categorized into Below types that held the largest Group B Streptococcus (GBS) Infection Treatment market share In 2023.
Prenatal-onset Gbs Disease
Early-onset Gbs Disease
Late-onset Gbs Disease
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Group B Streptococcus (GBS) Infection Treatment Market Research Analysis
1. Introduction of the Global Group B Streptococcus (GBS) Infection Treatment Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Group B Streptococcus (GBS) Infection Treatment Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Group B Streptococcus (GBS) Infection Treatment Market, By Type
6. Global Group B Streptococcus (GBS) Infection Treatment Market, By Application
7. Global Group B Streptococcus (GBS) Infection Treatment Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Group B Streptococcus (GBS) Infection Treatment Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/